Regeneron Pharmaceuticals (REGN)
Stock-Based Compensation
$986.70M
TTM · Period ending: · USD

REGN Stock-Based Compensation
Latest reported$986.70Mperiod ending
Latest reported$986.70Mperiod ending
REGN TTM Stock-Based Comp ($0.00 → $986.70M)
TTM stock-based compensation
High-resolution chart · PNG
REGN stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |